Catherine Moltzan

425 total citations
10 papers, 216 citations indexed

About

Catherine Moltzan is a scholar working on Hematology, Genetics and Management of Technology and Innovation. According to data from OpenAlex, Catherine Moltzan has authored 10 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 2 papers in Genetics and 2 papers in Management of Technology and Innovation. Recurrent topics in Catherine Moltzan's work include Platelet Disorders and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Catherine Moltzan is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Catherine Moltzan collaborates with scholars based in Canada and United States. Catherine Moltzan's co-authors include David R. Anderson, Stephen Couban, Susan Nahirniak, Heather Hume, Stephen H. Nantel, Ralph M. Meyer, Victor S. Blanchette, Graham F. Pineo, Kaiser Ali and Anne McLeod and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Hematology.

In The Last Decade

Catherine Moltzan

9 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Moltzan Canada	6	125	62	45	31	27	10	216
Enric Contreras Spain	9	151 1.2×	65 1.0×	46 1.0×	74 2.4×	16 0.6×	11	301
Claudia Djambas Khayat Lebanon	11	177 1.4×	39 0.6×	13 0.3×	35 1.1×	29 1.1×	38	316
Kerry L. O’Brien United States	10	123 1.0×	31 0.5×	34 0.8×	38 1.2×	21 0.8×	24	278
Tanya Petraszko Canada	10	160 1.3×	18 0.3×	33 0.7×	48 1.5×	23 0.9×	25	313
Suar Çakı Kılıç Türkiye	10	134 1.1×	30 0.5×	21 0.5×	25 0.8×	17 0.6×	31	268
Hamna J. Qureshi United Kingdom	6	203 1.6×	8 0.1×	53 1.2×	63 2.0×	16 0.6×	7	279
Marzena Dębska Poland	10	114 0.9×	15 0.2×	40 0.9×	22 0.7×	50 1.9×	43	329
B. Wibaut France	10	228 1.8×	3 0.0×	27 0.6×	60 1.9×	22 0.8×	31	307
Linda Schönborn Germany	12	322 2.6×	21 0.3×	23 0.5×	15 0.5×	333 12.3×	30	476

Countries citing papers authored by Catherine Moltzan

Since Specialization

Citations

This map shows the geographic impact of Catherine Moltzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Moltzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Moltzan more than expected).

Fields of papers citing papers by Catherine Moltzan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Moltzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Moltzan. The network helps show where Catherine Moltzan may publish in the future.

Co-authorship network of co-authors of Catherine Moltzan

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Moltzan. A scholar is included among the top collaborators of Catherine Moltzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Moltzan. Catherine Moltzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ng, David P., et al.. (2021). Pax-5 negative B-cell Lymphoma. SHILAP Revista de lepidopterología. 25. 200474–200474.

Houston, Brett L., et al.. (2019). A Case of Waldenstrom’s Macroglobulinemia Morphologically Resembling Plasma Cell Myeloma. Journal of Hematology. 8(1). 26–28. 1 indexed citations

Moltzan, Catherine, et al.. (2018). The Second Victim Phenomenon: Perspective of Canadian Radiation Therapists. Journal of medical imaging and radiation sciences. 50(1). 87–97. 11 indexed citations

Ross, Stephanie, et al.. (2018). How nonrandomized trials (NRT) inform pan-Canadian Oncology Drug Review (pCODR) expert review committee (pERC) recommendations in blood cancer.. Journal of Clinical Oncology. 36(30_suppl). 100–100. 2 indexed citations

Lin, Yulia, Catherine Moltzan, & David R. Anderson. (2012). The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework. Transfusion Medicine. 22(6). 383–394. 19 indexed citations

Moltzan, Catherine, David R. Anderson, Jeannie Callum, et al.. (2008). The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework. Transfusion Medicine. 18(2). 112–120. 12 indexed citations

Anderson, David R., Kaiser Ali, Victor S. Blanchette, et al.. (2007). Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions. Transfusion Medicine Reviews. 21(2 Suppl 1). S9–S56. 145 indexed citations

Moltzan, Catherine, et al.. (2005). Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient. American Journal of Hematology. 80(4). 288–291. 6 indexed citations

Rock, G., et al.. (2003). Automated collection of blood components: their storage and transfusion. Transfusion Medicine. 13(4). 219–225. 4 indexed citations

10.

Moltzan, Catherine, et al.. (2001). Perceptions and motivations of Canadian autologous blood donors. Transfusion Medicine. 11(3). 177–182. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact